(b).
Author, year | Aim | Sample's characteristics | Experimental protocols | Samples obtained | Oxidative or inflammatory main results |
---|---|---|---|---|---|
Belda et al. 2008 [96] | Type of sport (aquatic or terrestrial) and cell count∗ | Elite healthy athletes and with asthma | Comparison of baseline samples between healthy and asthmatic athletes who practice water sports in pools or terrestrially (T: ~20 h/wk, with the exception of healthy subjects in water with T: ~10 h/wk) | IS | There was a positive correlation between PMNs with training time and water sport in the pool |
| |||||
Carraro et al. 2006 [97] | eNO in regular attendance to swimming pools∗ | Children swimmers attending and control children not attending the swimming pool | Comparison of baseline samples between swimmers who attended a swimming pool (1 h/week/6 months) and control subjects | EB | There were no differences in eNO between both groups |
| |||||
Ferdinands et al. 2008 [98] | Exercise in contaminated environment and inflammation | Cross-country athletes and healthy control subjects | Comparison of baseline samples before and after 10 workouts in 15 d (~1 h/d) | EB | <pH in cross-country athletes compared to their control subjects between their respective sample times |
| |||||
Heinicke et al. 2009 [47] | Pulmonary oxidative damage and prolonged stay in medium height training∗ | Biathletes and sedentary control subjects | Comparison of baseline samples between biathlete (T: ~5 h/wk) and control subjects; both groups were exposed to 2800 MASL during the 6 weeks | EBC | [H2O2] and [8-isoprostane PGF2 α] with no differences between groups; by gathering data ↑ [H2O2] and tendency to ↑ [8-isoprostane PGF2 α] |
| |||||
Helenius et al. 1998 [99] | AWs inflammation in swimmers | Elite swimmers and nonathletic control subjects | Comparison of baseline samples between swimmers (T: 800–3380 km/year) and control subjects | IS | >Eosinophils, >PMNs, >[EPO], and >[human neutrophil lipocalin] in swimmers in comparison to control subjects |
| |||||
Helenius et al. 2002 [100] | Retirement from swimming in relation to AWs inflammation | High performance swimmers | Comparison of baseline samples between active (T: ~1870 km/year) and inactive swimmers (3 months of inactivity) | IS | >eosinophils and >lymphocytes in active swimmers than inactive swimmers |
| |||||
Karjalainen et al. 2000 [101] | Inflammatory cells in skiers, mild asthmatics, and healthy control subjects∗ | Elite healthy skiers and nonathletic control subjects | Comparison of baseline samples between skiers (T: 200–630 h/year) and control subjects | Endobronchial biopsy | >lymphocytes-T (43 times), >MØ (26 times), >eosinophils (2 times), and >PMNs (2 times) in skiers in comparison to control subjects |
| |||||
Martin et al. 2012 [102] | AWs inflammation and exposure to swimming pool in athletes∗ | Endurance athletes | Comparison of baseline samples of pool based (5 h/wk) and non-pool-based (0.5 h/wk) athletes (T: ~15 h/wk) | EB and IS | PMNs and eosinophils in IS and eNO in EB were not different between groups |
| |||||
Sue-Chu et al. 1999 [103] | AWs inflammation in skiers | Cross-country skiers and nonathletic control subjects | Comparison of baseline samples during the competitive period, in autumn and winter, between skiers (T: 435 h/year) and control subjects | BALF | >total cells, >lymphocytes, and >mast cells in skiers in comparison to control subjects, with no differences in [TNF-α] and [MPO] |
| |||||
Sue-Chu et al. 2000 [104] | Budesonide and AWs inflammation in skiers∗ | Elite cross-country skiers with asthmatic symptoms and budesonide or placebo supplementation | Comparison of baseline samples among skiers, after 20 weeks of supplementation with 800 µg/d budesonide (T: ~427 h/year) or placebo (T: ~468 h/year) | BALF and endobronchial biopsy | Lymphocytes, MØ, eosinophils, PMNs, and mast cells were not different between groups |
AWs: airways; BALF: bronchoalveolar lavage fluid; EB: exhaled breath; EBC: exhaled breath condensate; EPO: eosinophil peroxidase; H2O2: hydrogen peroxide; IS: induced sputum; 8-isoprostane PGF2α: 8-isoprostane prostaglandin F2 alpha; MØ: macrophages; MPO: myeloperoxidase; NO: nitric oxide; PMNs: polymorphonuclear neutrophils; T: training volume; TNF-α: tumor necrosis factor-alpha. In “Aim,” ∗the effect of exercise was not the primary aim of the study.